Study examines how fasting impacts physical activity motivation and weight reduction in patients on GLP-1 drugs, with implications for optimizing lifestyle during treatment.
Key findingStudy examines how fasting impacts physical activity motivation and weight reduction in patients on
What the researchers found
Study examines how fasting impacts physical activity motivation and weight reduction in patients on GLP-1 drugs, with implications for optimizing lifestyle during treatment.
Why it matters
Relevant to expanding peptide-based therapeutic applications.
The numbers in context
Qualitative study conducted during and after Ramadan 2024 at a Saudi Arabian university clinic.
How the study worked
Methodology detailed in publication.
Who was studied
Adults using GLP-1 drugs (semaglutide/tirzepatide) during Ramadan 2024 in Saudi Arabia
What this study cannot tell us
Limitations in publication.
How to read the evidence
Based on study design in publication.
When this study was published
Published in 2025.
The bigger picture
Contributes to the growing evidence for peptide therapeutics.
Questions still open
- Long-term implications?
- Comparison to existing evidence?
- Next research steps?
Common questions
What does this mean?
How reliable?
Read the original research
Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.
Patient preference and adherence, 19, 19-28
Citation
Almaqhawi, Abdullah; Alabdulqader, Razan Anwar; Alkhteeb, Nurah Abdullatef; Alomair, Fai Ibrahim; Alhassan, Sarra Riyadh; Alnajjar, Jawad S. (2025). Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.. Patient preference and adherence, 19, 19-28. https://doi.org/10.2147/PPA.S496613